BP Clenbuterol 40

BP Clenbuterol 40: Dosage, Fat Loss & Bodybuilding Guide

BP Clenbuterol 40 is Body Pharm’s 40 mcg clenbuterol hydrochloride tablet, used off-label by physique athletes in two-week on/off blocks during cutting phases. Clenbuterol is a long-acting beta-2 adrenergic agonist that was originally developed as an asthma bronchodilator and has never been approved for human use as a fat-loss agent. In South Africa it is a Schedule 4 prescription-only medicine, so anything below is context for informed adults, not a dosing recommendation.

What you’ll learn in this guide:

• What BP Clenbuterol 40 is, how the beta-2 mechanism is thought to drive fat loss, and why the evidence base is thinner than the bodybuilding reputation suggests.
• The off-label dose ranges reported in the peer-reviewed literature, and why a two-week on/off framework is used.
• Where the real cardiac risks sit — drawn from human case reports rather than marketing claims.
• How BP Clenbuterol 40 compares to HD Labs Clenbuterol 40 on the same storefront, and the current legal position in South Africa and under the anti-doping code.

Key Takeaways

• BP Clenbuterol 40 is a 40 mcg/tab oral clenbuterol HCl product from Body Pharm, used off-label for cutting cycles, typically in on/off blocks.
• Its appeal is thermogenic: as a beta-2 agonist it raises resting metabolic rate and fat oxidation, but no controlled weight-loss trials have been run in non-asthmatic adults, so human efficacy figures should be treated with caution.
• Beta-2 receptors desensitise with continuous use, which is the rationale behind on/off cycling.
• The dose-limiting problem is cardiac: tachycardia, tremor, hypokalaemia and arrhythmias are documented, and human case reports describe myocardial infarction and myocarditis — in one case at just 40 µg/day for a week.
• Clenbuterol is prohibited at all times as a WADA S1.2 “Other Anabolic Agent” and is a Schedule 4 medicine in South Africa; it is not FDA-approved for human use.

Safety note. The dose ranges below reflect off-label figures reported in the published literature, not a protocol we endorse. Clenbuterol has a narrow margin between its thermogenic effect and cardiac toxicity, adverse events have been reported even at low doses, and anyone considering it should do so only under the care of a doctor who can screen for cardiac contraindications first.

What Is BP Clenbuterol 40 and Who Makes It?

BP Clenbuterol 40 is Body Pharm’s oral clenbuterol hydrochloride tablet dosed at 40 mcg per tab, sold as a beta-2 adrenergic agonist (a drug that stimulates beta-2 receptors to relax airway smooth muscle and, off-label, to trigger lipolysis). Body Pharm packs it in blister strips; confirm the current tablet count on the product page before you order, as pack sizes change between restocks.

Some readers ask whether brand really matters at this dose. It does, because an underdosed or contaminated tablet makes any mcg-per-day plan meaningless — and because clenbuterol’s toxicity is dose-dependent, an over-strength tablet is a genuine hazard, not just wasted money.

Specifications worth confirming before purchase:

1. Manufacturer: Body Pharm (BP), a sports-pharmacology brand producing oral and injectable performance compounds.
2. Active ingredient: clenbuterol hydrochloride, 40 mcg per tablet. After an oral dose, plasma levels peak at roughly 2.5 hours and the drug has a long half-life of about 35 hours.
3. Tablet format: tablets are commonly split to reach smaller increments; a scored tablet makes 20 mcg (½ tab) steps easier.
4. Regulatory status: a Schedule 4 prescription-only medicine in South Africa; not approved for human use in the US and covered by FDA Import Alert 66-41; and prohibited in sport at all times.

The closest direct alternative on the same storefront is HD Labs Clenbuterol 40, also 40 mcg/tab, compared head-to-head later in this guide. For a pre-built combination, the BP CY Clenbuterol and Yohimbine Combo pairs the same clenbuterol dose with yohimbine HCl.

How Clenbuterol Burns Fat

Clenbuterol is thought to drive fat loss by binding beta-2 adrenergic receptors on fat and muscle, activating a cAMP cascade that raises resting metabolic rate and fat oxidation. The effect is sympathomimetic but receptor-selective, distinct from caffeine or yohimbine, which act mainly through adenosine antagonism or alpha-2 blockade rather than direct beta-2 agonism.

Readers often ask whether this means clen “works while you sit still.” Only partly: mobilised fatty acids are still oxidised only if you are in a calorie deficit — without that deficit they re-esterify rather than burn. Much of the supporting evidence for the thermogenic and muscle effects comes from rodent studies rather than controlled human trials, so treat the fat-loss reputation as plausible but under-evidenced in people.

The broad sequence usually described is:

1. Receptor binding: clenbuterol binds beta-2 adrenergic receptors on adipocytes and skeletal muscle.
2. cAMP elevation: G-protein-coupled signalling raises intracellular cAMP and activates hormone-sensitive lipase.
3. Lipolysis: stored triglycerides are hydrolysed into glycerol and free fatty acids that enter plasma.
4. Thermogenesis: core body temperature and metabolic rate rise, with pharmacological effects from a single oral dose persisting for about six hours and plasma concentrations peaking near 2.5 hours.
5. Sustained metabolic elevation: clenbuterol’s ~35-hour half-life keeps low levels circulating between doses, with steady state reached after a few days of repeated dosing.

Stacking alpha-2 antagonism on top — the logic behind the BP CY Clenbuterol and Yohimbine Combo — is intended to target the alpha-2-dense subcutaneous deposits (lower abdomen, glutes) that beta-2 agonism alone is said to leave behind.

Widely repeated fat-loss numbers (such as the often-cited “11.4 kg” figure) come from older or animal data and have not been replicated in a modern human RCT; treat them as indicative only. The recent peer-reviewed literature on clenbuterol is dominated by misuse, contamination and cardiac-safety reports rather than new efficacy trials.

Clenbuterol for Bodybuilding: Fat Loss vs Lean Muscle Retention

Clenbuterol is a fat-loss compound with a mild anti-catabolic side effect, not an anabolic steroid, despite its locker-room reputation. Beta-2 stimulation reduces protein degradation and modestly raises protein synthesis in animal models, but robust human hypertrophy evidence is lacking. The realistic use case is holding lean mass in a deficit, not adding it.

Why Clen Lives in Cutting Phases

Running clen during a bulk wastes the compound: a caloric surplus suppresses net lipolysis regardless of cAMP elevation, while the cardiovascular load (elevated resting heart rate, tremor, sleep disruption) adds to the recovery cost of heavy training. The window most users describe is the final weeks of a cut, when calories are below maintenance and preserving muscle is the priority.

The “Non-Steroidal Steroid” Myth

The label is wrong. Clenbuterol does not bind the androgen receptor, does not aromatise, and does not suppress the hypothalamic-pituitary-testicular axis. It mimics one downstream effect of anabolic steroids (nitrogen retention) through a different mechanism. Because it has no androgenic activity, the classic androgenic side effects (acne, accelerated hair loss, prostate hypertrophy) do not apply — but neither do steroid-level gains, and treating clen as a testosterone substitute leads to disappointment.

Why Female Athletes Consider Clen

Because clenbuterol carries no androgenic conversion, women using it avoid the virilisation risks (voice deepening, clitoral hypertrophy) associated with oral anabolic steroids — the main reason some female physique competitors prefer beta-2 agonists for cutting. That is a difference in side-effect profile, not evidence of safety: the cardiac risks below apply to everyone, and no female-specific efficacy trial exists in the indexed literature.

Clenbuterol is prohibited in and out of competition as an S1.2 Other Anabolic Agent, so tested-federation athletes should not use it. If you are not tested, HD Labs Clenbuterol 40 is the equivalent BP alternative on this storefront.

BP Clenbuterol 40 Dosage: The 2-Week On/Off Framework

The two-weeks-on / two-weeks-off pattern exists because beta-2 receptors downregulate with chronic clenbuterol exposure, blunting the thermogenic response no matter how much the dose is escalated. Time off is meant to restore receptor sensitivity; escalating the dose to “push through” desensitisation does not work, because the receptor population itself shrinks.

For reference, the published literature describes the therapeutic asthma dose as 20–40 µg twice daily, with off-label “fat-burning” and athletic use reported in the 60–160 µg/day range over 6–12 weeks. Higher figures carry disproportionately higher cardiac risk for little extra fat loss, which is why experienced users treat roughly 120 µg/day as a practical ceiling and start far lower. First-time users, smaller individuals and women typically begin at 20 mcg (half a 40 mcg tablet) and titrate slowly while tracking resting heart rate and tremor, stopping the climb as soon as side effects appear rather than chasing a target number.

Why There Is No “Safe” Self-Titration

There is no validated human dosing schedule for clenbuterol as a fat-loss drug, because it has never been studied for that purpose in non-asthmatic adults. Any titration table circulating online is anecdotal. The genuinely important variables to monitor are cardiac — resting heart rate, palpitations, and blood pressure — and the safest version of this decision is made with a doctor and a baseline ECG, not from a spreadsheet.

BP Clenbuterol 40 vs HD Labs Clenbuterol 40

Both products are 40 mcg/tablet clenbuterol hydrochloride. The pharmacology, the on/off rationale, and the cardiac cautions apply identically. The decision is brand ecosystem and stack compatibility, not potency.

A reasonable concern: is one safer or stronger than the other? On declared label spec, no — the active and strength match. Real-world variance lives in batch quality and excipients, which is why some users rotate suppliers across cycles.

Pull live pricing from the BP Clenbuterol 40 product page and the HD Labs Clenbuterol 40 product page before purchase; pack sizes and per-tablet costs shift across restocks.

Side-by-Side Spec Sheet

Spec	BP Clenbuterol 40	HD Labs Clenbuterol 40
Manufacturer	Body Pharm	HD Labs
Tablet strength	40 mcg	40 mcg
Active ingredient	Clenbuterol HCl	Clenbuterol HCl
Pack size	Verify on product page	Verify on product page
Price per tablet	Verify on product page	Verify on product page
Stack compatibility	Pairs with the BP CY combo and BP CYT3	Pairs with HD Labs T3 and yohimbine SKUs
Typical user	Building a Body Pharm cutting stack	Already running HD Labs orals

Whichever brand you choose, clenbuterol is prohibited at all times under WADA Section S1.2 (Other Anabolic Agents), with no in- or out-of-competition allowance.

Stacking BP Clenbuterol 40

Stacking is meant to attack lipolysis through parallel pathways (beta-2 agonism, alpha-2 antagonism, thyroid-driven metabolic rate), but every added compound also adds cardiovascular and central-nervous-system load, so individual doses come down — the effects do not stack cleanly, and neither do the risks. Combining unapproved compounds compounds the cardiac hazard, so this section is context, not encouragement.

1. Clen + Yohimbine (BP CY combo). Yohimbine HCl blocks alpha-2 adrenoreceptors that otherwise brake lipolysis in stubborn depots. The pre-built BP CY Clenbuterol and Yohimbine Combo removes the split-dosing maths, but both are stimulants, so resting heart rate will already sit well above baseline — keep the clen dose conservative.
2. Clen + T3 (BP CYT3 combo). Exogenous T3 (liothyronine) raises basal metabolic rate while clen handles peripheral lipolysis; the BP CYT3 SKU bundles all three actives. T3 can catabolise lean mass without adequate protein and training support, so this is an advanced, higher-risk combination.
3. Brand-rotation option. Athletes anchored to HD Labs orals can substitute HD Labs Clenbuterol 40 into the same framework; the mechanism is identical, only the manufacturer batch changes.

Because human case reports link clenbuterol to myocardial infarction and myocarditis, stacking — which pushes total stimulant load higher — moves you toward that risk window faster. Track resting heart rate and blood pressure daily and stop the cycle if either climbs and stays high.

Side Effects and How to Manage Them

Clenbuterol’s adverse effects are dose-dependent beta-2 overstimulation phenomena. The most common, per the published toxicity profile, are tachycardia, tremor, hypokalaemia (low potassium), sweating, headache, muscle cramps, insomnia and cardiac arrhythmias. Tremor and sweating often ease after the first week; the cardiac effects do not necessarily settle with continued use.

1. Tachycardia and palpitations. Resting heart rate rises during a cycle. Stop if morning heart rate stays elevated for consecutive days or if palpitations occur at rest — these are the warning signs that precede the serious cardiac events below.
2. Hand tremors. Worst in week one and tend to attenuate as receptors downregulate. Splitting the daily dose can reduce peak tremor.
3. Muscle cramps. Linked to potassium and taurine shifts; adequate hydration and electrolytes (potassium, magnesium) help. Cramps that persist usually indicate dehydration rather than a supplement deficiency.
4. Insomnia. Because of the ~35-hour half-life, dose early in the day; late dosing reliably wrecks sleep.
5. Headaches, sweating and jitteriness. Central sympathomimetic load; keep additional stimulants (caffeine, pre-workouts) low while on cycle.

Hard contraindications: pre-existing cardiomyopathy, uncontrolled hypertension, hyperthyroidism, a history of arrhythmia such as atrial fibrillation, or current SSRI/MAOI use. Get a resting ECG and, ideally, an echocardiogram before considering a first cycle.

Dose conservatism reduces but does not remove cardiac risk. A published case report describes clenbuterol-induced myocarditis — with raised troponin and delayed epicardial enhancement on cardiac MRI — in a patient taking only 40 µg/day for one week, and separate reports document myocardial infarction in young bodybuilders. Cardiac hypertrophy and fibrosis have also been shown in rodents given high chronic doses. If you want the alpha-2 layer with a more predictable stimulant ceiling, the BP CY Clenbuterol and Yohimbine Combo and the HD Labs Clenbuterol 40 tablet carry the identical side-effect profile at matched dose.

Legal Status in South Africa and Under WADA

Clenbuterol is a Schedule 4 substance under South Africa’s Medicines and Related Substances Act, meaning it is a prescription-only medicine. There is no SAHPRA-registered clenbuterol product indicated for weight loss, so any fat-loss use is off-label and outside the terms of registration.

Before you consider it, understand three things:

1. South African status: as a Schedule 4 medicine, clenbuterol is legally dispensed only on a valid prescription; it is not an approved over-the-counter slimming aid.
2. Anti-doping status: clenbuterol is listed under WADA Section S1.2 (Other Anabolic Agents), prohibited in and out of competition with no threshold below which it is permitted. Any athlete under a WADA-code federation should not use it.
3. International status: the FDA has never approved clenbuterol for human use — the only US approval is a veterinary bronchodilator — and unapproved human-use tablets fall under FDA Import Alert 66-41. European human bronchodilator brands (Spiropent, Dilaterol) are licensed in their own jurisdictions but are not FDA-approved.

How to Buy BP Clenbuterol 40 on Beskinny

Order BP Clenbuterol 40 directly from the Beskinny product page. It is made by Body Pharm (BP), the same lab behind the BP CY and BP CYT3 combos, which keeps batch sourcing consistent if you later add to it.

Before you check out:

1. Verify the listing. Confirm “Body Pharm” and the 40 mcg/tab strength; counterfeits often misspell the manufacturer or misstate the strength.
2. Compare the alternative. HD Labs Clenbuterol 40 is the same dose at a different price point; choose on cost-per-mcg, not branding.
3. Consider a pre-built combo. The BP CY Clenbuterol and Yohimbine Combo saves sourcing yohimbine separately for the alpha-2 layer.
4. Cross-shop the category. Beskinny’s weight-loss tablets range sits alongside its GLP-1, HGH and peptide inventory.
5. Talk to a doctor first. Because clenbuterol is prescription-only and carries real cardiac risk, get medical screening before your first cycle.

Frequently Asked Questions About BP Clenbuterol 40

How many BP Clenbuterol 40 tablets per day?

There is no validated human dose for fat loss. Off-label use reported in the literature falls in the 60–160 µg/day range (roughly 1.5–4 tablets), but cardiac risk rises with dose, so most non-competitive users treat about 120 µg/day as a ceiling and titrate up slowly from a single tablet while watching resting heart rate. This is background information, not a prescription.

How long does clenbuterol take to work?

Cardiovascular and thermogenic effects begin within an hour of an oral dose, with peak plasma concentration around 2.5 hours. Any visible fat loss depends on a sustained caloric deficit over weeks, not on the drug alone — and controlled human weight-loss data simply do not exist, so avoid trusting specific “kg per cycle” promises.

Can I take clenbuterol without a diet?

No. Clenbuterol can only amplify an existing caloric deficit by raising metabolic rate; it does not create a deficit. Eating at maintenance while taking it produces tremor, tachycardia and cramping with negligible fat loss.

Is BP Clenbuterol 40 the same as Spiropent, Ventipulmin, or Dilaterol?

Same active ingredient (clenbuterol HCl), different brand and regulatory context. Spiropent and Dilaterol are European human-prescription bronchodilators; Ventipulmin is a veterinary product. BP Clenbuterol 40 is a 40 mcg oral tablet manufactured by Body Pharm for the research/underground market — the same molecule, with different excipients and quality control, and still Schedule 4 in South Africa.

What is the difference between clenbuterol and anabolic steroids?

Clenbuterol is a beta-2 adrenergic agonist, not an anabolic-androgenic steroid. It drives cAMP-mediated lipolysis and mild protein-sparing without binding the androgen receptor, so it causes no virilisation, testicular suppression or estrogenic effects. Confusingly, though, WADA still classifies it as an S1.2 Other Anabolic Agent, prohibited at all times, because of its muscle-sparing action.

Should I buy the BP version or the HD Labs version?

Decide on cost-per-mcg, not branding. The HD Labs Clenbuterol 40 tablet delivers identical 40 mcg dosing, while the BP CY Clenbuterol and Yohimbine Combo is the better pick if you want the alpha-2 layer bundled in. Whichever you choose, the cardiac cautions and prescription-only status are the same.

References

1. Clenbuterol Abuse in Bodybuilding and Athletics: Unsupervised Use, Psychological Motivations, and Health Consequences. Cureus, 2025.
2. The Prohibited List (S1.2 Other Anabolic Agents). World Anti-Doping Agency, 2026.
3. Consolidated Schedules (Medicines and Related Substances Act) — Schedule 4. South African Health Products Regulatory Authority (SAHPRA), 2025.
4. Import Alert 66-41: Detention Without Physical Examination of Unapproved New Drugs Promoted in the U.S.. U.S. Food and Drug Administration.